Search Within

Mark Kris

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (44)
  2. Meeting Abstract (28)
  3. Conference Paper (1)
Groups
  1. Department of Medicine (73)
  2. Sloan Kettering Institute Postdocs (73)
  3. Solid Tumor Oncology Division (73)
  4. Thoracic Oncology (73)
  5. Department of Pathology and Laboratory Medicine (63)
  6. GSK Faculty (61)

More Groups

People
  1. Gregory Riely (45)
  2. Marc Ladanyi (44)
  3. Charles Rudin (36)
  4. Alexander Drilon (30)
  5. Helena Yu (30)
  6. Maria Arcila (30)

More People

Years
  1. 2025 (1)
  2. 2024 (6)
  3. 2023 (12)
  4. 2022 (4)
  5. 2021 (2)
  6. 2020 (5)

More Years

Publications
  1. Journal of Clinical Oncology (16)
  2. Clinical Cancer Research (14)
  3. Journal of Thoracic Oncology (14)
  4. Annals of Oncology (3)
  5. Cancer Discovery (3)
  6. JCO Precision Oncology (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (19)
  2. American Association for Cancer Research (18)
  3. Elsevier Inc. (15)
  4. Nature Publishing Group (5)
  5. Oxford University Press (4)
  6. Mosby Elsevier (2)

More Publishers

Results (73)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Histologic patterns of lung cancers associated with MET exon 14 splice site alterations (MESSA): A study of 58 Cases
    Meeting Abstract

    Montecalvo, J.; Alex, D.; Lai, V.; Kris, M.; Drilon, A.; Arcila, M. E.; Ladanyi, M.; Rekhtman, N.; Travis, W.
    Modern Pathology (2017)

    Fulltext@MSK | Save
  • Histologic patterns of lung cancers associated with MET exon 14 splice site alterations (MESSA): A study of 58 cases
    Meeting Abstract

    Montecalvo, J.; Alex, D.; Lai, V.; Kris, M.; Drilon, A.; Arcila, M. E.; Ladanyi, M.; Rekhtman, N.; Travis, W.
    Laboratory Investigation (2017)

    Fulltext@MSK | Save
  • A Phase 1/2 trial of ruxolitinib and erlotinib in patients with EGFR-mutant lung adenocarcinomas with acquired resistance to erlotinib
    Journal Article

    Yu, H. A.; Perez, L.; Chang, Q.; Gao, S. P.; Kris, M. G.; Riely, G. J.; Bromberg, J.
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • MDM2 amplification (Amp) to mediate cabozantinib resistance in patients (Pts) with advanced RET-rearranged lung cancers
    Meeting Abstract

    Somwar, R.; Smith, R.; Hayashi, T.; Ishizawa, K.; Charen, A. S.; Khodos, I.; Mattar, M.; He, J.; Balasubramanian, S.; Stephens, P.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Cabozantinib in patients with advanced RET-rearranged non-small-cell lung cancer: an open-label, single-centre, phase 2, single-arm trial
    Journal Article

    Drilon, A.; Rekhtman, N.; Arcila, M.; Wang, L.; Ni, A.; Albano, M.; Van Voorthuysen, M.; Somwar, R.; Smith, R. S.; Montecalvo, J.; more...
    Lancet Oncology (2016)

    Fulltext@MSK | Save
  • Clinical outcomes with pemetrexed-based systemic therapies in RET-rearranged lung cancers
    Journal Article

    Drilon, A.; Bergagnini, I.; Delasos, L.; Sabari, J.; Woo, K. M.; Plodkowski, A.; Wang, L.; Hellmann, M. D.; Joubert, P.; Sima, C. S.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • A novel crizotinib-resistant solvent-front mutation responsive to cabozantinib therapy in a patient with ROS1-rearranged lung cancer
    Journal Article

    Drilon, A.; Somwar, R.; Wagner, J. P.; Vellore, N. A.; Eide, C. A.; Zabriskie, M. S.; Arcila, M. E.; Hechtman, J. F.; Wang, L.; Smith, R. S.; more...
    Clinical Cancer Research (2016)

    Fulltext@MSK | Save
  • Clinical outcomes with pemetrexed-based systemic therapy in RET-rearranged lung cancers
    Meeting Abstract

    Drilon, A.; Bergagnini, I.; Delasos, L.; Sima, C. S.; Smith, R.; Somwar, R.; Riely, G. J.; Kris, M. G.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Phase II study of cabozantinib for patients with advanced RET-rearranged lung cancers
    Meeting Abstract

    Drilon, A. E.; Sima, C. S.; Somwar, R.; Smith, R.; Ginsberg, M. S.; Riely, G. J.; Rudin, C. M.; Ladanyi, M.; Kris, M. G.; Rizvi, N. A.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Identification of KIF5B-RET and GOPC-ROS1 fusions in lung adenocarcinomas through a comprehensive mRNA-based screen for tyrosine kinase fusions
    Journal Article

    Suehara, Y.; Arcila, M.; Wang, L.; Hasanovic, A.; Ang, D.; Ito, T.; Kimura, Y.; Drilon, A.; Guha, U.; Rusch, V.; more...
    Clinical Cancer Research (2012)

    Fulltext@MSK | Save